In the same way, Iarlori et al [31] found higher levels of CCL5 in PBMCs from AD patients compared to controls, but the mean ± SD of MMSE score of AD patients was 21 ± 3, most of the patients included were mild AD patients. Here, CCL5 is linked to Alzheimer disease.